Oculis Holding AG (OCS) Operating Income (2022 - 2026)

Oculis Holding AG (OCS) recorded quarterly Operating Income of $266894.0 in Q1 2026, down 48.1% quarter-over-quarter from $514230.8 in Q4 2025, and down 15.8% on a YoY basis from $316991.4 in Q1 2025.

Oculis Holding AG (OCS) Operating Income (2022 - 2026) Analysis & Trends

Oculis Holding AG's Operating Income history runs 5 years deep, the most recent figure standing at $266894.0 for Q1 2026.

  • In Q1 2026, Operating Income fell 15.8% year-over-year to $266894.0; the TTM figure through Mar 2026 stood at $1.1 million (down 99.97% YoY), while the FY2025 annual figure was $1.5 million, up 91.57% from the prior year.
  • Operating Income was $266894.0 for Q1 2026 at Oculis Holding AG, down from $514230.8 in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $3.4 billion in Q4 2024 to a low of $249.31 in Q3 2024.
  • Historically, Operating Income has averaged $214.3 million across 5 years, with a median of $251765.9 in 2022.
  • The sharpest annual moves came in 2024 and 2025: Operating Income surged 1641900.41% in 2024, then plunged 99.98% in 2025.
  • A 5-year view of Operating Income shows it stood at $222136.7 in 2022, then slipped by 6.11% to $208560.6 in 2023, then surged by 1641900.41% to $3.4 billion in 2024, then slumped by 99.98% to $514230.8 in 2025, then tumbled by 48.1% to $266894.0 in 2026.
  • The last three Operating Income figures came in at $266894.0 (Q1 2026), $514230.8 (Q4 2025), and $303.78 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -32.68 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -2.97 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -19.70 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -15.76 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -3.82 Mn
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 1.14 Bn
9 Abivax 90.15 Bn 90.15 Bn - -65.83 Mn
10 Oculis Holding AG 8.23 Bn 7.92 Bn - 266,893.98

Historic Data

Download Data
DateValue
Mar 31, 2026 266,893.98
Dec 31, 2025 514,230.78
Sep 30, 2025 303.78
Jun 30, 2025 315,259.35
Mar 31, 2025 316,991.40
Dec 31, 2024 3.42 Bn
Sep 30, 2024 249.31
Jun 30, 2024 270,919.40
Mar 31, 2024 254,341.47
Dec 31, 2023 208,560.58
Sep 30, 2023 247,941.41
Jun 30, 2023 278,043.89
Mar 31, 2023 247,586.23
Dec 31, 2022 222,136.69
Sep 30, 2022 209,162.24
Jun 30, 2022 249,190.32